Prospective REgistry of Targeted RadionucLide TherapY in Patients With mCRPC (REALITY Study)
N/A
This prospective registry aims to assess outcome and toxicity of targeted r...
Status
Unknown
Location
Dept. of Nuclear Medicine, Saarland University
Start Date
2016-01-01
Trial ID
NCT04833517
Samarium Sm 153 Lexidronam Pentasodium and 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate Cancer
PHASE2
RATIONALE: Giving samarium Sm 153 lexidronam pentasodium and 3-dimensional ...
Samarium Sm 153 Lexidronam Pentasodium Combined With Zoledronic Acid or Pamidronate in Treating Patients With Relapsed or Refractory Multiple Myeloma and Bone Pain
PHASE1
RATIONALE: Radioactive drugs, such as samarium Sm 153 lexidronam pentasodiu...